Clinical Trials
2 trialsNCT07514065 2026-04-07
TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy
Tasly Pharmaceutical Group Co., Ltd
Phase 1 Recruiting
NCT03643107 2025-01-23
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Allarity Therapeutics
Phase 2 Completed